Related Articles
Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer
Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes
Clinicopathological features and prognosis of breast cancer with low HER2 status evaluated by fluorescence <em>in situ</em> hybridization
Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: Gene amplification does not contribute to EGFR expression
Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients